Published in ScientificWorldJournal on June 18, 2012
Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children. BMC Pediatr (2014) 0.87
High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. PLoS One (2015) 0.86
Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. Int J Mol Sci (2016) 0.80
Use of corticosteroids during acute phase of Kawasaki disease. World J Clin Pediatr (2015) 0.77
Pediatric Biliary Interventions in the Native Liver. Semin Intervent Radiol (2016) 0.75
Fever and Jaundice in a Previously Healthy Teenager. Clin Pediatr (Phila) (2016) 0.75
Acute Acalculous Cholecystitis: A Rare Presentation of Primary Epstein-Barr Virus Infection in Adults-Case Report and Review of the Literature. Case Rep Infect Dis (2017) 0.75
Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease. Oncotarget (2017) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Kawasaki syndrome. Lancet (2004) 5.09
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol (2007) 2.81
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J (1998) 2.53
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13
Kawasaki disease: A brief history. Pediatrics (2000) 1.63
Acalculous cholecystitis in children. J Pediatr Surg (1996) 1.52
The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol (1986) 1.50
Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol (2002) 1.43
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr (2010) 1.38
Kawasaki disease. Pediatr Clin North Am (1995) 1.35
Mucocutaneous lymph node syndrome (MLNS) in the continental United States. Pediatrics (1976) 1.32
Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol (2012) 1.25
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr (2010) 1.22
ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One (2011) 1.21
Kawasaki syndrome: an update. Hosp Pract (Hosp Ed) (1982) 1.12
Coronary artery fistula associated with Kawasaki disease. Am Heart J (2009) 1.11
Acute acalculous cholecystitis. Complication of other illnesses in childhood. Arch Surg (1975) 1.10
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg (1987) 1.04
Acute acalculous cholecystitis in children: Diagnosis and treatment. J Pediatr Surg (2002) 1.03
Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin (2011) 0.98
CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease. J Clin Immunol (2010) 0.96
Sonography in the diagnosis and management of hydrops of the gallbladder in children with mucocutaneous lymph node syndrome. Pediatrics (1980) 0.95
Sonography of the normal pediatric gallbladder and biliary tract. Radiology (1982) 0.93
Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci (2008) 0.90
Septic shock and hypofibrinogenemia predict a fatal outcome in childhood acute acalculous cholecystitis. J Pediatr Gastroenterol Nutr (2011) 0.88
Surgical complications of Kawasaki disease. J Pediatr Surg (1981) 0.88
Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children. J Clin Immunol (2011) 0.86
Sonography of the acute abdomen in the pediatric patient. J Ultrasound Med (2002) 0.85
Mucocutaneous lymph node syndrome: report of two cases complicated by gallbladder hydrops and diagnosed by ultrasound. Pediatrics (1978) 0.83
Kawasaki disease complicated by gallbladder hydrops mimicking acute abdomen: a report of three cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1990) 0.83
Gallbladder hydrops in mucocutaneous lymph node syndrome. South Med J (1989) 0.82
Kawasaki disease: who is at risk? J Pediatr (2000) 0.79
Kawasaki syndrome: report of four cases with acute gallbladder hydrops. J Pediatr Surg (1984) 0.79
Ultrasonographic evaluation of the gallbladder in mucocutaneous lymph node syndrome. Radiology (1982) 0.77
The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol (2007) 2.81
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology (2008) 2.32
Laboratory diagnostics of dengue fever: an emphasis on the role of commercial dengue virus nonstructural protein 1 antigen rapid test. J Microbiol Immunol Infect (2012) 2.32
miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid (2010) 2.30
Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology (2010) 2.10
Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology (2011) 2.07
Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res (2003) 2.01
Epidemiological features of CKD in Taiwan. Am J Kidney Dis (2007) 1.86
Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am J Trop Med Hyg (2008) 1.75
Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J (2005) 1.69
Shock wave therapy for calcific tendinitis of the shoulder: a prospective clinical study with two-year follow-up. Am J Sports Med (2003) 1.69
Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis (2010) 1.64
Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. Arthritis Rheumatol (2015) 1.63
OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J (2011) 1.53
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg (2009) 1.50
Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr (2002) 1.50
Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model. BJU Int (2012) 1.49
Variations of prothrombin time and international normalized ratio in patients treated with warfarin. Thromb Res (2002) 1.48
Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J Allergy Clin Immunol (2003) 1.46
Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg (2005) 1.45
Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am (2005) 1.44
Role of the acid-sensing ion channel 3 in blood volume control. Circ J (2011) 1.43
Partial protein-hydrolyzed infant formula decreased food sensitization but not allergic diseases in a prospective birth cohort study. Int Arch Allergy Immunol (2010) 1.42
Acute hepatitis A infection in children: a 20-year experience of a medical center in Southern Taiwan. Acta Paediatr Taiwan (2007) 1.42
Statin use and the risk of liver cancer: a population-based case–control study. Am J Gastroenterol (2010) 1.40
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr (2010) 1.38
Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J (2009) 1.36
Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem (2003) 1.35
Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg (2009) 1.33
Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients. Int J Infect Dis (2010) 1.32
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet (2012) 1.30
The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys (2006) 1.29
Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary pre-fatal clinical and laboratory manifestations. PLoS Negl Trop Dis (2012) 1.25
Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol (2012) 1.25
Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol (2009) 1.24
Extracorporeal shock waves promote healing of collagenase-induced Achilles tendinitis and increase TGF-beta1 and IGF-I expression. J Orthop Res (2004) 1.23
Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res (2004) 1.22
Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg (2007) 1.21
ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One (2011) 1.21
Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases. Am J Trop Med Hyg (2006) 1.21
Small bowel intussusception in symptomatic pediatric patients: experiences with 19 surgically proven cases. World J Surg (2002) 1.19
Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis (2002) 1.19
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet (2010) 1.19
Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol (2002) 1.18
Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia. Ann Hematol (2014) 1.16
Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol (2006) 1.14
Role of acid-sensing ion channel 3 in sub-acute-phase inflammation. Mol Pain (2009) 1.14
Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.13
Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem (2002) 1.12
Ectopic pelvic kidney with urinary tract infection presenting as lower abdominal pain in a child. Pediatr Neonatol (2011) 1.12
Understanding sensory nerve mechanotransduction through localized elastomeric matrix control. PLoS One (2009) 1.11
Coronary artery fistula associated with Kawasaki disease. Am Heart J (2009) 1.11
Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology (2011) 1.10
Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg (2007) 1.09
DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis (2011) 1.09
Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol (2008) 1.09
Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells. Cell Signal (2011) 1.09
Nociceptors of dorsal root ganglion express proton-sensing G-protein-coupled receptors. Mol Cell Neurosci (2007) 1.08
Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev (2008) 1.08
Effects of Asian dust storm events on hospital admissions for chronic obstructive pulmonary disease in Taipei, Taiwan. Inhal Toxicol (2008) 1.08
Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol (2005) 1.08
Cocktail therapy for femoral head necrosis of the hip. Arch Orthop Trauma Surg (2010) 1.07
Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis. PLoS One (2011) 1.07
Long-term results of extracorporeal shockwave treatment for plantar fasciitis. Am J Sports Med (2006) 1.06
Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology (2005) 1.04
IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol (2005) 1.04
A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol (2009) 1.03
Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics (2003) 1.01
Shock wave treatment shows dose-dependent enhancement of bone mass and bone strength after fracture of the femur. Bone (2004) 1.00
Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. J Neurosci (2011) 1.00
Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide (2010) 1.00
Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cells. J Biol Chem (2011) 1.00
Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet (2011) 1.00
Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect (2007) 1.00
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One (2013) 0.99
Internal hernia associated with Meckel's diverticulum in 2 pediatric patients. Am J Emerg Med (2008) 0.99
Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. J Cell Physiol (2011) 0.99
Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Pediatr Cardiol (2010) 0.99